Viewing Study NCT03111069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-05-16 @ 6:29 PM
Study NCT ID: NCT03111069
Status: WITHDRAWN
Last Update Posted: 2018-07-20
First Post: 2017-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Neoplasms of Mesothelial and Soft Tissue View
None Rhabdomyosarcoma, Pelvic View
None Rhabdomyosarcoma, Abdominal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant neoplasms of mesothelial and soft tissue View
None Pelvic and Abdominal Rhabdomyosarcoma View
None Undifferentiated Sarcomas View
None Unresectable or Refractory View
None Abdominal tumors View
None Hyperthermic intra-peritoneal chemotherapy View
None HIPEC View
None Abdominal surgery View
None Doxorubicin View
None Doxorubicin Hydrochloride View
None Adriamycin PFS View
None Adriamycin RDF View
None Adriamycin View
None Rubex View
None Intra-operative radiation View
None IORT View
None Brachytherapy View